| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.4 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |